ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO1069

Profiles of Dialysis Recovery Time in Incident Home and In-Center Hemodialysis

Session Information

  • Home Hemodialysis
    November 09, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Dialysis

  • 702 Dialysis: Home Hemodialysis

Authors

  • Danziger, John, Harvard Medical School, Brookline, Massachusetts, United States
  • Larkin, John W., Fresenius Medical Care North America, Waltham, Massachusetts, United States
  • Jiao, Yue, Fresenius Medical Care North America, Waltham, Massachusetts, United States
  • Reviriego-Mendoza, Marta, Fresenius Medical Care North America, Waltham, Massachusetts, United States
  • Chaudhuri, Sheetal, Fresenius Medical Care North America, Waltham, Massachusetts, United States
  • Long, Andrew, Fresenius Medical Care North America, Waltham, Massachusetts, United States
  • Willetts, Joanna, Fresenius Medical Care North America, Waltham, Massachusetts, United States
  • Maddux, Dugan, Fresenius Medical Care North America, Waltham, Massachusetts, United States
  • Hymes, Jeffrey L., Fresenius Medical Care North America, Waltham, Massachusetts, United States
  • Usvyat, Len A., Fresenius Medical Care North America, Waltham, Massachusetts, United States
  • Thadhani, Ravi I., Cedars-Sinai, Los Angeles, California, United States
  • Maddux, Franklin W., Fresenius Medical Care, Waltham, Massachusetts, United States
Background

Home hemodialysis (HHD) includes frequent treatments typically 4-6 times per week and yields a higher adequacy and fluid removal. HHD associates to reductions in dialysis recovery time (DRT) compared to in-center HD (ICHD) in prevalent patients who switch to the modality. DRT is a measure of the perceived time after HD a patient feels they can return to performing normal daily activities. We characterized the profiles of DRT in incident patients treated with HHD and ICHD.

Methods

We used data from adult incident HD patients treated at a large dialysis provider who completed a DRT survey ≤180 days from the first date of dialysis (FDD) during 2014 to 2017. DRT survey is administered with the annual KDQOL questionnaire and asks: “How long does it take you to be able to return to your normal activities after your dialysis treatment?” Categorical answers include: <0.5, 0.5-1, 1-2, 2-4, >4 hours. We calculated the percentage of patients in DRT categories for the HHD and ICHD groups.

Results

We analyzed data from 1091 HHD and 98616 ICHD patients who completed the DRT survey ≤180 days from FDD. A lower proportion of HHD patients reported DRT >1 hour compared to ICHD (Figure 1). About half of HHD patients (53.9%) and a quarter (25.2%) of ICHD patients reported a DRT <0.5 hour.

Conclusion

Incident HD patients treated by HHD appear to experience a shorter DRT compared to ICHD. These findings show consistent signals with the Frequent Hemodialysis Network trial results in prevalent HD (Garg Kidney Int. 2017). Patients who chose HHD modality may be younger and have distinct clinical presentations and adjusted analysis are needed to substantiate these findings.

Funding

  • Commercial Support –